Errors in Key Points, Abstract, Results, and Discussion
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMeta-analysis and systematic reviews · Reliability and Agreement in Measurement · Behavioral and Psychological Studies
In the Original Investigation titled “Subsequent Meningiomas Among Survivors of Childhood Cancer,”^1^ published December 11, 2025, there were errors in the Key Points, Abstract, Results, and Discussion, in which it was incorrectly reported that 6-mercaptopurine (6-MP) was the antimetabolite exposure. However, in all analyses, the antimetabolite exposure was actually modeled as a composite class variable that included methotrexate, 6-MP, 6-thioguanine, and cytarabin. The language throughout the article has been updated to antimetabolite chemotherapy. The authors have explained the error in a Comment.^2^ This article has been corrected.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bowers DC, Cooney T, Chen Y, . Subsequent meningiomas among survivors of childhood cancer. JAMA Netw Open. 2025;8(12):e 2548715. doi:10.1001/jamanetworkopen.2025.4871541379444 PMC 12699355 · doi ↗ · pubmed ↗
- 22. Bowers D. Author response to Acar/Correction. JAMA Network Open. Published December 31, 2025. Accessed January 23, 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842656